Literature DB >> 8904447

Immunodetection of Pneumocystis carinii in bronchoalveolar lavage specimens compared with methenamine silver stain.

I Lautenschlager1, O Lyytikainen, L Jokipii, A Jokipii, A Maiche, T Ruutu, P Tukiainen, P Ruutu.   

Abstract

Immunodetection of Pneumocystis carinii, based on immunofluorescence and use of a monoclonal antibody specific for an antigen located within the cyst wall and detectable after trypsin digestion only, was compared with a methenamine silver stain in 553 bronchoalveolar lavage specimens from immunosuppressed patients. P. carinii was found by immunofluorescence in 72 (86%) and by silver stain in 68 (81%) of the total of 84 positive samples detected by either or both of these methods.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8904447      PMCID： PMC228879          DOI： 10.1128/jcm.34.3.728-730.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

1.  A stain for fungi in tissue sections and smears using Gomori's methenamine-silver nitrate technic.

Authors:  R G GROCOTT
Journal:  Am J Clin Pathol       Date:  1955-08       Impact factor: 2.493

2.  Bronchoalveolar lavage. Influence of cytologic methods on the cellular picture.

Authors:  E Taskinen; P Tukiainen; R Renkonen
Journal:  Acta Cytol       Date:  1992 Sep-Oct       Impact factor: 2.319

3.  Problems in the detection of Pneumocystis carinii by indirect immunofluorescence.

Authors:  M Koch; W Heizmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-01       Impact factor: 3.267

4.  Pneumocystis carinii pneumonitis in adults with acute lymphoblastic leukaemia.

Authors:  D W Milligan; G M Smith; M R Howard; D L Barnard; D R Norfolk; J A Child
Journal:  Lancet       Date:  1987-04-11       Impact factor: 79.321

5.  Monoclonal antibody to detect Pneumocystis carinii.

Authors:  E Linder; K Elvin; A Bjorkman; S Bergdahl; L Morfeldt-Mansson; L Moberg; A Sonnerborg
Journal:  Lancet       Date:  1986-09-13       Impact factor: 79.321

6.  Detection of Pneumocystis carinii by fluorescent-antibody stain using a combination of three monoclonal antibodies.

Authors:  V J Gill; G Evans; F Stock; J E Parrillo; H Masur; J A Kovacs
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

7.  Bronchoalveolar lavage and transbronchial biopsy for the diagnosis of pulmonary infections in the acquired immunodeficiency syndrome.

Authors:  C Broaddus; M D Dake; M S Stulbarg; W Blumenfeld; W K Hadley; J A Golden; P C Hopewell
Journal:  Ann Intern Med       Date:  1985-06       Impact factor: 25.391

8.  Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunosuppressed host.

Authors:  D E Stover; M B Zaman; S I Hajdu; M Lange; J Gold; D Armstrong
Journal:  Ann Intern Med       Date:  1984-07       Impact factor: 25.391

9.  Pneumocystis carinii pneumonia in renal-transplant recipients treated with cyclosporine and steroids.

Authors:  A M Hardy; C P Wajszczuk; A F Suffredini; T R Hakala; M Ho
Journal:  J Infect Dis       Date:  1984-02       Impact factor: 5.226

10.  Prospective evaluation of a monoclonal antibody in diagnosis of Pneumocystis carinii pneumonia.

Authors:  J A Kovacs; V Gill; J C Swan; F Ognibene; J Shelhamer; J E Parrillo; H Masur
Journal:  Lancet       Date:  1986-07-05       Impact factor: 79.321
View more
  3 in total

1.  Comparison of three cost effective staining methods for detection of Pneumocystis jirovecii.

Authors:  Mohamad Mohsen Homayouni; Ali Rostami; Hamed Gholizadeh; Amir Sayed Ali Mehbod; Maryam Ebrahimi; Saeed Mehravar
Journal:  J Parasit Dis       Date:  2016-06-02

2.  (1-3)-beta-D-glucan in association with lactate dehydrogenase as biomarkers of Pneumocystis pneumonia (PcP) in HIV-infected patients.

Authors:  F Esteves; C-H Lee; B de Sousa; R Badura; M Seringa; C Fernandes; J F Gaspar; F Antunes; O Matos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-03       Impact factor: 3.267

3.  Cost-effectiveness analysis of diagnostic options for pneumocystis pneumonia (PCP).

Authors:  Julie R Harris; Barbara J Marston; Nalinee Sangrujee; Desiree DuPlessis; Benjamin Park
Journal:  PLoS One       Date:  2011-08-15       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.